Dextropropoxyphene: Dextropropoxyphene was withdrawn from the US and European markets in 2010 due to serious cardiac toxicity, including QT prolongation and fatal arrhythmias at therapeutic doses. The drug causes seizures and potentially fatal cardiac complications that cannot be reversed by naloxon
Related pages